BC
Broadfin Capital Portfolio holdings
AUM
$403M
This Quarter Return
+15.53%
1 Year Return
+74.97%
3 Year Return
+245.63%
5 Year Return
+336.04%
10 Year Return
–
AUM
$1.52B
AUM Growth
+$1.52B
(+21%)
Cap. Flow
+$94.4M
Cap. Flow
% of AUM
6.2%
Top 10 Holdings %
Top 10 Hldgs %
46.09%
Holding
98
New
17
Increased
26
Reduced
19
Closed
7
Top Buys
| 1 |
NVRO
NEVRO CORP.
NVRO
|
$22.6M |
| 2 |
RPTP
RAPTOR PHARMACEUTICAL CORP COM STK (DE)
RPTP
|
$20.8M |
| 3 |
PTX
Pernix Therapeutics Holdings, Inc.
PTX
|
$17.2M |
| 4 |
Zevra Therapeutics
ZVRA
|
$15.2M |
| 5 |
CYNA
CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA)
CYNA
|
$13.9M |
Top Sells
| 1 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
$77.7M |
| 2 |
Travere Therapeutics
TVTX
|
$26.5M |
| 3 |
Heron Therapeutics
HRTX
|
$12.8M |
| 4 |
Amphastar Pharmaceuticals
AMPH
|
$12.5M |
| 5 |
UAM
Universal American Corp
UAM
|
$12.1M |
Sector Composition
| 1 | Healthcare | 92.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Dynavax Technologies
DVAX
$1.19B
| $17.9M | 0.96% |
766,010
| – | – |
|
27
Catalyst Pharmaceutical
CPRX
$2.42B
| $17.3M | 0.93% |
4,183,177
+100,000
| +2% | +$413K |
|
|
PETX
28
DELISTED
Aratana Therapeutics, Inc.
PETX
| $17.1M | 0.92% |
1,131,865
| – | – |
|
29
Iovance Biotherapeutics
IOVA
$800M
| $16.6M | 0.89% |
1,812,419
+750,000
| +71% | +$6.88M |
|
|
DSCI
30
DELISTED
Derma Sciences, Inc. Common Stock (DE)
DSCI
| $16.6M | 0.89% |
2,317,489
+187,012
| +9% | +$1.34M |
|
|
ATRS
31
DELISTED
Antares Pharma, Inc.
ATRS
| $15.8M | 0.85% |
7,575,000
+2,875,000
| +61% | +$5.98M |
|
|
32
Zevra Therapeutics
ZVRA
$501M
| $15.2M | 0.82% |
+827,810
| New | +$15.2M |
|
|
TLGT
33
DELISTED
Teligent, Inc
TLGT
| $14.4M | 0.77% |
2,287,728
+1,287,728
| +129% | +$8.11M |
|
|
CYNA
34
DELISTED
CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA)
CYNA
| $13.9M | 0.75% |
+878,117
| New | +$13.9M |
|
|
GNCA
35
DELISTED
Genocea Biosciences, Inc.
GNCA
| $13.7M | 0.74% |
996,760
-38,240
| -4% | -$525K |
|
|
PRTK
36
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
| $13.7M | 0.73% |
530,283
+270,000
| +104% | +$6.96M |
|
37
AtriCure
ATRC
$1.73B
| $11.9M | 0.64% |
483,354
-50,000
| -9% | -$1.23M |
|
|
ANTH
38
DELISTED
Anthera Pharmaceuticals, Inc.
ANTH
| $11.8M | 0.63% |
1,370,457
-1,050,000
| -43% | -$9.05M |
|
|
MRTX
39
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $11.3M | 0.61% |
359,661
+53,198
| +17% | +$1.67M |
|
|
ELOS
40
DELISTED
Syneron Medical Ltd
ELOS
| $10.7M | 0.57% |
1,005,221
| – | – |
|
41
Arcturus Therapeutics
ARCT
$467M
| $10.3M | 0.56% |
1,579,806
+23,790
| +2% | +$156K |
|
42
ADMA Biologics
ADMA
$4.03B
| $8.93M | 0.48% |
964,193
| – | – |
|
43
Ardelyx
ARDX
$1.57B
| $8.88M | 0.48% |
+649,290
| New | +$8.88M |
|
|
TRVN
44
DELISTED
Trevena, Inc.
TRVN
| $8.82M | 0.47% |
1,409,153
| – | – |
|
|
AMRN
45
Amarin Corp
AMRN
$311M
| $8.67M | 0.47% |
3,525,216
+2,533,333
| +255% | +$6.23M |
|
46
KalVista Pharmaceuticals
KALV
$713M
| $8.43M | 0.45% |
+1,178,941
| New | +$8.43M |
|
47
Fate Therapeutics
FATE
$115M
| $8.41M | 0.45% |
1,300,000
+1,229,572
| +1,746% | +$7.96M |
|
48
iRadimed
IRMD
$898M
| $8.28M | 0.44% |
355,684
-1,680
| -0.5% | -$39.1K |
|
|
BLRX
49
BioLineRX
BLRX
$15.5M
| $8.25M | 0.44% |
3,100,000
| – | – |
|
50
Veracyte
VCYT
$2.41B
| $8.2M | 0.44% |
+736,196
| New | +$8.2M |
|